Related Experiment Video
Updated: Apr 27, 2026

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
Published on: May 26, 2023
Current therapeutic approaches to cardio-protection in hypertension
1Section of Clinical Pharmacy, Veterans Affairs Medical Center West Palm Beach, 7305 North Military Trail, West Palm Beach, FL, 33410, USA, David.Parra@va.gov.
Insights
New hypertension guidelines offer improved blood pressure measurement techniques and re-evaluated targets. These advancements aim to further reduce cardiovascular risk in hypertensive patients through updated therapeutic strategies.
Area of Science:
- Cardiology
- Hypertension Management
- Preventive Medicine
Background:
- Current hypertension management focuses on risk-based blood pressure targets and stepwise pharmacotherapy.
- Traditional approaches involve drug selection based on compelling indications and titration to achieve target blood pressure.
- The established methods have been instrumental in reducing cardiovascular risk in patients with hypertension.
Purpose of the Study:
- To review emerging evidence on blood pressure measurement.
- To discuss re-evaluated blood pressure targets for hypertension.
- To explore novel therapeutic strategies for cardiovascular risk reduction.
Main Methods:
- Literature review of recent advancements in blood pressure monitoring.
- Analysis of updated clinical guidelines and research on hypertension targets.
- Synthesis of new therapeutic approaches in hypertension management.
Main Results:
- Improved accuracy and accessibility in blood pressure measurement techniques are now available.
- Re-evaluation suggests potentially lower or more individualized blood pressure targets.
- Emerging therapies offer additional avenues for cardiovascular risk mitigation.
Conclusions:
- Recent advancements in blood pressure measurement and target re-evaluation present opportunities for enhanced hypertension care.
- Integrating these new findings into clinical practice may lead to superior cardiovascular risk reduction.
- A paradigm shift towards more precise and personalized hypertension management is indicated.
Abstract:
Targeting a specific blood pressure based upon patient risk has been the approach to reducing cardiovascular risk in patients with hypertension. Drug selection was based upon compelling indications with titration and the addition of other agents as needed until the blood pressure target was achieved. However, new information has emerged describing improved methods for measuring blood pressure, a re-evaluation of blood pressure targets and additional therapeutic approaches that together may further reduce cardiovascular risk in patients with hypertension.
More Related Videos
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Hypertension IV: Drug Therapy and Lifestyle Modifications
Heart Failure V: Medical Management
Cardiomyopathy V: Interprofessional Care
Coronary Artery Disease V: Interprofessional Care
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...

